{
    "organizations": [],
    "uuid": "364f367c98a9be442595a45fe87701e05d9139db",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-acer-therapeutics-q4-loss-per-shar/brief-acer-therapeutics-q4-loss-per-share-0-63-idUSASB0C999",
    "ord_in_thread": 0,
    "title": "BRIEF-Acer Therapeutics Q4 Loss Per Share $0.63",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7 (Reuters) - Acer Therapeutics Inc:\n* ACER THERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE\n* Q4 LOSS PER SHARE $0.63 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-08T05:37:00.000+02:00",
    "crawled": "2018-03-08T17:05:40.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "acer",
        "therapeutic",
        "inc",
        "acer",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "financial",
        "result",
        "provides",
        "corporate",
        "update",
        "q4",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}